Published in Blood Weekly, December 6th, 2001
"Although the association of the number of donor T cells with the clinical outcome has been studied extensively, the optimum number of progenitor cells that should be administered to patients is unknown," explained Alvaro Urbano-Ispizua and colleagues at the University of Barcelona's August Pi i Sunyer Institute for Biomedical Research.
While the dangers of insufficient stem cell grafts are well...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.